THE POWER OF VIBRANCE
BSE SENSEX
73,847.15
-379.93 -0.51%
09 Apr 25 | 16:00 | Close

Get Quote

Aarti Pharmalabs Ltd

5
(AARTIPHARM | 543748 | INE0LRU01027)
626.60 -15.65 (-2.44%)
09 Apr 25 | 16:00 | All Prices in   


Previous Close 642.25
Open 628.65
High 633.05
Low 594.25
VWAP 617.63
52 Wk High 837.00
52 Wk Low 429.50
Upper Price Band 751.90
Lower Price Band 501.30
Price Band 20%
TTQ (Lakh) 0.33
Turnover (Cr.) 2.04
2W Avg Qty`(Lakh) 0.56
Mcap Full (Cr.) 5,679.17
Mcap FF (Cr.) 3,122.43
EPS (TTM) 25.55
CEPS (TTM) 33.88
PE/PB 24.52 / 3.33
ROE 13.56
Face Value 5.00
Category Listed
Group / Settlement Type A /T+1
Index BSE SmallCap
Basic Industry Pharmaceuticals

Corporate Announcements
Segment :
Announcement Submission Type :
From Date
To Date
Category
Sub Category
     Current Page Number 1 out of 1
No of Announcements 17 Till Date 08 Apr 2025
 
Company : Aarti Pharmalabs Ltd
08 Apr 2025
543748  |   Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 Company Update 2.30 MB XBRL
Certificate for the quarter ended March 31, 2025
  Exchange Received Time 08-04-2025 11:17:44 Exchange Disseminated Time 08-04-2025 11:17:44 Time Taken 00:00:00
 
543748  |   Announcement under Regulation 30 (LODR)-Joint Venture Company Update 0.35 MB XBRL
Entering into addendum to the Subscription and Shareholders'' agreement
  Exchange Received Time 01-04-2025 08:10:06 Exchange Disseminated Time 01-04-2025 08:10:06 Time Taken 00:00:00
 
543748  |   Closure of Trading Window Insider Trading / SAST 0.43 MB XBRL
Closure of Trading Window
  Exchange Received Time 20-03-2025 17:00:39 Exchange Disseminated Time 20-03-2025 17:00:39 Time Taken 00:00:00
 
543748  |   Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS Company Update 0.57 MB XBRL
Allotment of Shares under PSOP 2023
  Exchange Received Time 10-03-2025 17:53:49 Exchange Disseminated Time 10-03-2025 17:53:50 Time Taken 00:00:01
 
543748  |   Announcement under Regulation 30 (LODR)-Earnings Call Transcript Company Update 0.96 MB XBRL
Transcript of Q3/9M Earnings Conference call
  Exchange Received Time 12-02-2025 16:39:48 Exchange Disseminated Time 12-02-2025 16:39:48 Time Taken 00:00:00
 
543748  |   Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Company Update 0.43 MB XBRL
Recording of the Earnings Conference call for Q3 FY 25
  Exchange Received Time 07-02-2025 18:29:39 Exchange Disseminated Time 07-02-2025 18:29:39 Time Taken 00:00:00
 
543748  |   Announcement under Regulation 30 (LODR)-Newspaper Publication Company Update 0.96 MB XBRL
Newspaper Publication of the Audited Financial Results for Quarter ended December 31, 2024
  Exchange Received Time 07-02-2025 11:33:44 Exchange Disseminated Time 07-02-2025 11:33:44 Time Taken 00:00:00
 
543748  |   Announcement under Regulation 30 (LODR)-Investor Presentation Company Update 3.36 MB XBRL
Investor Presentation for the Quarter ended December 31, 2024
  Exchange Received Time 06-02-2025 16:42:01 Exchange Disseminated Time 06-02-2025 16:42:01 Time Taken 00:00:00
 
543748  |   Record Date For Interim Dividend Corp. Action 0.50 MB XBRL
Record Date for Interim Dividend
  Exchange Received Time 05-02-2025 19:36:14 Exchange Disseminated Time 05-02-2025 19:36:14 Time Taken 00:00:00
 
543748  |   Corporate Action-Board to consider Dividend Corp. Action 0.50 MB XBRL
Board approved the Interim Dividend
  Exchange Received Time 05-02-2025 19:34:32 Exchange Disseminated Time 05-02-2025 19:34:32 Time Taken 00:00:00
 
543748  |   Integrated Filing (Financial) Integrated Filing 9.17 MB XBRL
Integrated Filing (Financials) for the Quarter ended December 31, 2024
  Exchange Received Time 05-02-2025 19:25:34 Exchange Disseminated Time 05-02-2025 19:25:35 Time Taken 00:00:01
 
543748  |   Financial Results For Quarter Ended December 31, 2024 Result 8.73 MB XBRL
Financials Results for Quarter ended December 31, 2024
  Exchange Received Time 05-02-2025 19:16:50 Exchange Disseminated Time 05-02-2025 19:16:50 Time Taken 00:00:00
 
543748  |   Board Meeting Outcome for Financial Results For Quarter Ended December 31, 2024 Board Meeting 8.73 MB XBRL
Financial Results For Quarter Ended December 31, 2024
  Exchange Received Time 05-02-2025 19:11:38 Exchange Disseminated Time 05-02-2025 19:11:46 Time Taken 00:00:08
 
543748  |   Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Company Update 1.14 MB XBRL
This is to inform you that the Earnings Conference Call for Investors and Analysts, which would be a Group meet, has been scheduled on Friday, February 07, 2025 at 04:00 p.m. (IST) to discuss .... Read More..
  Exchange Received Time 28-01-2025 11:50:33 Exchange Disseminated Time 28-01-2025 11:50:33 Time Taken 00:00:00
 
543748  |   Board Meeting Intimation for Audited Financial Results Of The Company For The Quarter And Nine-Months Ended December 31, 2024 And 2. Declaration Of Interim Dividend, If Any, On The Equity Share Capital Of The Company For The Financial Year 2024-25. Board Meeting 0.42 MB XBRL
Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2025 ,inter alia, to consider and approve 1. Audited Financial Results .... Read More..
  Exchange Received Time 28-01-2025 11:19:28 Exchange Disseminated Time 28-01-2025 11:19:30 Time Taken 00:00:02
 
543748  |   Re-Opening Of Manufacturing Activities At The Company'S Vapi Plant Company Update 0.52 MB XBRL
Re-opening of Manufacturing activities at the Company''s Vapi Plant
  Exchange Received Time 18-01-2025 15:09:52 Exchange Disseminated Time 18-01-2025 15:09:52 Time Taken 00:00:00
 
543748  |   Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 Company Update 0.52 MB XBRL
Certificate for the Quarter ended December 31, 2024
  Exchange Received Time 10-01-2025 10:58:08 Exchange Disseminated Time 10-01-2025 10:58:08 Time Taken 00:00:00
 
     Current Page Number 1 out of 1



Site optimized for IE9 & above. | Disclaimer | Website Policies | Privacy Policy | Sitemap Copyright © BSE Ltd. All Rights Reserved.
11 Apr 25 | 12:28 (IST)
(20H)